PROCEPT BioRobotics (NASDAQ: PRCT) net income
PROCEPT BioRobotics reported a net loss of $95.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $91.4m. Earnings per share were −$1.72.
PROCEPT BioRobotics's best year of the last 6 was fiscal 2020. It reported a loss in 6 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$95.6m | — | −31.0% | −$1.72 |
| 2024 | −$91.4m | — | −40.7% | −$1.75 |
| 2023 | −$105.9m | — | −77.8% | −$2.24 |
| 2022 | −$87.2m | — | −116.2% | −$1.96 |
| 2021 | −$59.9m | — | −173.6% | −$3.63 |
| 2020 | −$53.0m | — | −687.0% | −$14.47 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
PROCEPT BioRobotics net income compared with its sector
By net income for its latest fiscal year, PROCEPT BioRobotics ranks 330th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of PROCEPT BioRobotics, −31.0%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 328th | Xencor | −$91.9m | −73.2% |
| 329th | Orthofix Medical | −$92.2m | −11.2% |
| 330th | PROCEPT BioRobotics | −$95.6m | −31.0% |
| 331st | AMN Healthcare Services | −$95.7m | −3.5% |
| 332nd | Prelude Therapeutics | −$99.5m | −819.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of PROCEPT BioRobotics
- How much did PROCEPT BioRobotics earn in fiscal 2025?
- PROCEPT BioRobotics reported a net loss of $95.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $91.4m.
- What are the earnings per share of PROCEPT BioRobotics?
- They were −$1.72 in fiscal 2025, compared with −$1.75 in fiscal 2024.
- Where does PROCEPT BioRobotics rank in its sector by net income?
- It ranks 330th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for PROCEPT BioRobotics come from?
- From the annual report (Form 10-K) that PROCEPT BioRobotics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that PROCEPT BioRobotics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on PROCEPT BioRobotics: the PROCEPT BioRobotics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.